Success Story: Ophthalmology Expert from Pakistan Achieves NIW Approval Without RFE

Posted by wegreened on April 1, 2026 in NIW, Ophthalmology

Client’s Testimonial:

"I am extremely happy and satisfied with the impeccable services provided to me."

On February 9^th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Reader/Imaging Scientist in the Field of Ophthalmology (Approval Notice).

General Field: Ophthalmology

Position at the Time of Case Filing: Reader/Imaging Scientist

Country of Origin: Pakistan

Country of Residence at the Time of Filing: Pakistan

Approval Notice Date: February 9^th, 2026

Processing Time: 18 months, 30 days

Case Summary:

"[Client]'s prowess in the early detection and treatment of retinal disease, and as well as her strong record of high-impact publications, situate her as a leader in the field and establish her inherent value to the United States."

The statement above is taken from one of two recommendation letters submitted as part of the EB-2 NIW (National Interest Waiver) petition for a researcher from Pakistan holding an M.Sc. in Primary Care Ophthalmology with advanced expertise in clinical ophthalmology and artificial intelligence applications in healthcare.

Client Background and Proposed Endeavor

As a reader/imaging scientist in the field of ophthalmology, the proposed endeavor is to continue research on advancing the reliability and reproducibility of artificial intelligence applications in ophthalmology, with particular focus on improving reporting standards for AI-based diagnostic trials and enhancing the early detection and treatment of retinal diseases. With extensive training in systematic review methodologies, AI-based medical diagnostics, and clinical research design, this researcher is actively advancing groundbreaking research in healthcare quality improvement with direct applications to evidence-based medicine and patient care optimization.

National Significance of the Research

We emphasized that this research is of significant importance and has far-reaching implications for the United States. The work directly addresses critical gaps in the standardization of AI methodologies in healthcare, contributing to the reliability and reproducibility of AI trials that are crucial for the national implementation of AI technologies in medical diagnostics.

Impressive Credentials and Achievements

To further strengthen the case, we highlighted exceptional credentials:

Publications: An impressive portfolio of 7 peer-reviewed journal articles (3 first-authored) and 5 abstracts (2 first-authored)
Citations: The work has been cited 214 times

Case Outcome

Considering the exceptional strength of the accomplishments and the national importance of the proposed endeavor, we are delighted to share that this NIW petition was approved in over 18 months without an RFE. The innovative work in AI healthcare standardization and clinical research methodology, combined with demonstrated expertise in ophthalmology and systematic review processes, positions this researcher to make transformative contributions to U.S. healthcare innovation, medical AI implementation, and patient care excellence for years to come.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%